Top Markets
#1 Pleasing Gold Pleasing Gold +1,501.37%
#2 PulseChain PulseChain +58.12%
#3 Ontology Gas Ontology Gas +39.10%
#4 Merlin's Seal BTC Merlin's Seal BTC +33.52%
#5 BOOK OF MEME BOOK OF MEME +28.96%
#6 Unit Pump Unit Pump +25.16%
#7 Pump.fun Pump.fun +25.16%
#8 ConstitutionDAO ConstitutionDAO +24.95%
#9 Neiro Neiro +23.96%
#10 Collect on Fanable Collect on Fanable +22.35%
Coin of the day
Pleasing Gold Pleasing Gold
Settings
Language
ENGLISH
Currency
USD
Theme
Ambalal Sarabhai Enterprises Limited Ambalal Sarabhai Enterprises Limited

Ambalal Sarabhai Enterprises Limited

AMBALALSA
Rank in Stocks #26491
Ambalal Sarabhai Enterprises Ltd. operates as a holding company with... Ambalal Sarabhai Enterprises Ltd. operates as a holding company with investments across the pharmaceutical and electrical industries. Its core activities include the production and marketing of pharmaceutical goods. The company was established on June 27, 1977, and its principal office is located in Ahmedabad, India.
Share Price
$0.52431453
Market Cap
$40.18M
Change (1 day)
2.15%
Change (1 year)
33.33%
Country
IN
Trade Ambalal Sarabhai Enterprises Limited (AMBALALSA)

Category

Healthcare
Revenue for Ambalal Sarabhai Enterprises Limited (AMBALALSA)
Revenue in Aug 2026 TTM: 0
According to Ambalal Sarabhai Enterprises Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Ambalal Sarabhai Enterprises Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT